SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Genetown
Tarveda’s Phase II Miniature Drug Conjugates Deliver Better Targeting, Less Toxicity than ADCs
Tarveda Therapeutics is advancing its miniature drug conjugates into Phase IIa trials, using a platform that combines the best aspects of small molecules and antibody drug conjugates while addressing their deficiencies.
August 6, 2020
 · 
4 min read
 · 
Gail Dutton
BioMidwest
Two Mass-Market, Paper-based COVID-19 Diagnostics Tests in Development
Researchers are developing simpler COVID-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.
August 5, 2020
 · 
4 min read
 · 
Gail Dutton
Drug Development
As Clinical Trials Go Digital, Complexity Grows Along with the Risk to Data Integrity
Data security risks are growing as more and more clinical trials embrace telemedicine and other digital technologies.
August 4, 2020
 · 
4 min read
 · 
Gail Dutton
Drug Development
uniQure Begins First-in-Human Gene Therapy Trials for Huntington’s Disease
In June, it dosed its first two patients using a novel therapeutic, AMT-130, delivered directly to the brain. Initial readouts are expected in a year’s time.
August 4, 2020
 · 
4 min read
 · 
Gail Dutton
Business
Johns Hopkins Outlines Public Health Challenges of Achieving Mass COVID-19 Vaccination
With billions of doses of COVID-19 vaccines expected to be available by year’s end, and a global population of 7.8 billion, public health officials are scrambling to deliver the vaccines in ways that are equitable and effective.
August 3, 2020
 · 
5 min read
 · 
Gail Dutton
Business
AAIC 2020: Multi-omics and Biomarkers Emerge as Key Elements in the Future of Alzheimer’s Research
A multi-omics, multi-algorithm approach will unleash a new wave of understanding around Alzheimer’s disease and diagnosis, that in time, will make precision diagnostics practical, speakers predicted at the Alzheimer’s Association International Conference 2020.
July 30, 2020
 · 
4 min read
 · 
Gail Dutton
Drug Development
Can a Coronavirus Vaccine Really be Ready This Year?
Ebola, HIV and Zika viruses became global challenges that caused researchers and vaccine developers to jump into action but, ultimately, vaccine development takes time. That’s why claims that SARS-CoV-2 vaccines will be available soon often are met with skepticism.
July 27, 2020
 · 
5 min read
 · 
Gail Dutton
Deals
Public and Private Biotech Investments Up Despite COVID-19 Slowdowns
COVID-19 put many businesses on hold, but not biotech. This sector is growing at record speeds, and only a small portion of the capital deals are related to the pandemic.
July 27, 2020
 · 
3 min read
 · 
Gail Dutton
Business
New Membrane Uses Pressure to Help Solve Bioprocess Waste Problem
A new membrane filtration method could solve the problem of the excessive bioprocessing wastes that many say is a prime impediment to manufacturing pharmaceuticals in the United States.
July 23, 2020
 · 
4 min read
 · 
Gail Dutton
Pictured: Healthcare working holding an injection/
Biotech Beach
Locanabio’s Combo RNA Modification Platform Targets Multiple RNA Dysfunctions with One Injection
Locanabio combines gene therapy with RNA modification for a novel, highly flexible platform that can modify, replace or eliminate dysfunctional RNA. Gene therapy and RNA modification have each been used before. It’s the combination that makes it unique.
July 22, 2020
 · 
4 min read
 · 
Gail Dutton
Business
Brand Institute: Highly Visual, Distinctive Brand Names are Trending for 2020
The trendy drug brand names for 2020 include Tepezza®, Zolgensma®, and Qvar®. Like the names of newborn children, they are designed to be visually distinctive and to make a statement.
July 17, 2020
 · 
4 min read
 · 
Gail Dutton
Business
BioSpace 2020 Salary Report Highlights Growing Gender Pay Gap and Other Vital Data
Today BioSpace released its second annual 2020 U.S. Life Sciences Salary Report, revealing surprising – and sometimes shocking – results. Here’s a look at some of the topline data.
July 15, 2020
 · 
3 min read
 · 
Gail Dutton
Business
IDbyDNA Brings Metagenomics to the COVID-19 Fight
Metagenomics can look across the entire genomic sequence of more than 50,000 species of organisms that may be present in a patient sample and compare millions of sequences from a patient with millions of reference sequences.
July 15, 2020
 · 
5 min read
 · 
Gail Dutton
Drug Development
UK Institute Develops Llama-Derived Nanobodies as Possible COVID-19 Therapy
Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.
July 15, 2020
 · 
4 min read
 · 
Gail Dutton
BioCapital
Can – and Should – Pharma Manufacturing Heed Calls to Come Home?
The COVID-19 pandemic underscored weaknesses in critical industries in the U.S. In the pharmaceutical industry, the global nature of the business, long considered a benefit, became not just a weakness but a national security threat.
July 13, 2020
 · 
4 min read
 · 
Gail Dutton
Load More